AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Arkaglip M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Arkaglip M 500mg/50mg Tablet

Metformin/Glibenclamide 500mg/50mg tablets manage elevated blood glucose in type 2 diabetes patients. This dual-action medication mitigates severe diabetic complications like nephropathy and vision impairment, potentially lessening cardiovascular events. Prescribed independently or adjunctively with other antidiabetic agents, its efficacy is maximized with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time optimizes therapeutic effects; discontinuation should only occur under physician guidance. Effective blood sugar regulation helps prevent future complications. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes management, as lifestyle significantly influences blood sugar control. Common adverse reactions include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential risk, especially with concomitant insulin or sulfonylurea use; proper recognition and management are essential. This medication isn't universally suitable. Prior medical history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption should be disclosed to your physician before initiation. Pregnant or lactating individuals require medical consultation. Interaction with other medications is possible; complete medication disclosure ensures safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout treatment.

Primary Ingredients of Arkaglip M 500mg/50mg Tablet

No text provided to rephrase.

Uses of Arkaglip M 500mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Arkaglip M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Arkaglip M 500mg/50mg Tablet with a meal.

Common Side effects of Arkaglip M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Arkaglip M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Arkaglip M 500mg/50mg tablets should be administered with a meal.

How Arkaglip M 500mg/50mg Tablet works:

Metformin and glimepiride, each 500mg and 50mg respectively, are combined in Arkaglip M tablets to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Arkaglip M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Arkaglip M 500mg/50mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Arkaglip M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Arkaglip M 500mg/50mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Arkaglip M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Arkaglip M 500mg/50mg Tablet :

Should you forget to take your Arkaglip M 500mg/50mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Arkaglip M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Arkaglip M 500mg/50mg Tablet

Arkaglip M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advised.
Nausea and vomiting are possible side effects of Arkaglip M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Arkaglip M 500mg/50mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Arkaglip M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Lactic acidosis, a serious medical emergency with elevated blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis), is a potential, though rare, side effect of Arkaglip M 500mg/50mg Tablet. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol consumers, hence its avoidance in these groups. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Arkaglip M 500mg/50mg Tablet and seek immediate medical attention.
Prolonged use of Arkaglip M 500mg/50mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Using Arkaglip M 500mg/50mg tablets as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially with insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Arkaglip M 500mg/50mg Tab...
125
MRP 145
13% off